But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. So should Burning Rock Biotech (NASDAQ:BNR) shareholders be worried about its cash burn?

A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...

The company’s strategic moves include a partnership ... Trending Articles Burning Rock Biotech NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

The company offers next-generation sequencing ... and Merck KGaA. Burning Rock Biotech Limited was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China.

In this article, we are going to take a look at where Scholar Rock Holding Corporation ... the industry into the spotlight. As major pharmaceutical companies began pursuing acquisitions, investor ...

becoming the company’s latest growth engine Cancer detection specialist Burning Rock Biotech Ltd. BNR has seen its revenue figures shoot upwards in the past few years, boosted by growing demand ...

Would the cost-cutting measures for U.S. prescription drugs proposed by the Trump administration on Monday hurt the biotech sector more than pharma? We asked Seeking Alpha analysts Stephen Ayers and ...

Burning Rock Biotech (BNR) has released an update ... which adjusted the ratio of its American depositary shares. The company successfully maintained a minimum closing bid price of $1.00 per ...

Scholar Rock has done well to advance its anti ... My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but ...

A biotech company that hoped to use cell biology to address neurological disorders is shutting down. Faze Medicines was built by VC Third Rock Ventures and launched in 2020 with $81 million from ...

Among the small bunch of billionaires that the local biotech industry has created ... and a publicly traded Cambridge company called Scholar Rock, after Springer’s favorite collectable object.